Skip to content

4Accepted Sep 15, 4:12 PM ET

International Stem Cell (ISCO) Director Paul Maier Sells 32,802 Shares

ISCOInternational Stem Cell CORP

Accepted (ET)

4:12 PM

Sep 15, 2026

Filed

Sep 15, 2026

Documents

1

Size

4.8 KB

Summary

International Stem Cell (ISCO) Director Paul Maier Sells 32,802 Shares

Updated

What Happened
Paul Maier, a director of International Stem Cell Corp (ticker: ISCO), disposed of 32,802 shares on September 11, 2026. The shares were sold at $0.32 per share for a total transaction value of approximately $10,497. This was a sale (disposition), which is often a routine insider transaction rather than a direct signal of company outlook.

Key Details

  • Transaction date: 2026-09-11; filing date: 2026-09-15 (filed within the typical 2-business-day window).
  • Transaction type: Sale (code S) — reported as an open-market or private sale.
  • Price per share: $0.32; shares sold: 32,802; total proceeds: ~$10,497.
  • Shares owned after transaction: Not specified in the summary provided here — see the Form 4 for post-transaction holdings.
  • Footnotes/notable items: None provided in the supplied details (no 10b5-1 plan, tax withholding, or option exercise noted).

Context
Sales by directors can be routine (liquidity, diversification, tax planning) and do not by themselves indicate management sentiment. Purchases generally carry more informational weight for investors. This report concerns a director (not a 10% owner or executive option exercise), and the transaction appears straightforward — a cash sale of existing shares. See the full Form 4 filing (Accession: 0001683168-26-007164) for complete holdings and any additional disclosures.

AI-written summary · check the filing